Groundbreaking research.
Community engagement.
Progress.

The ACTG is a global clinical trials network that conducts research to improve the management of HIV and its comorbidities; develop a cure for HIV; and innovate treatments for tuberculosis, hepatitis B, and emerging infectious diseases.

There are 15 currently enrolling trials across our research areas.

View All Trials

Our Areas of Research

Ribbon

HIV (and comorbidities)

7 enrolling trials
Ribbon

HIV cure

3 enrolling trials
lungs

Tuberculosis

2 enrolling trials
Liver

Hepatitis

1 enrolling trial
Covid

COVID-19

1 enrolling trial
Thermometer

Mpox

1 enrolling trial

Our Impact and Reach

Since our founding in 1987, ACTG investigators and sites across four continents have served as major resources for HIV and other infectious disease research, treatment, care, and education in their communities.

47k+

participants

76

sites

15

countries

3k+

trials

Where we are in the world

Voices for the Community

Anne Njoroge
Peter Thibodeaux
Moses Supercharger
jankosmyna@gmail.com
Jan Kosmyna, MIS, B.Ed., RN

North Royalton, Ohio

Sign up to receive the latest updates from the ACTG

Subscribe

ANNOUNCEMENTS

Annual Solicitation for ACTG Committee Membership Positions-Due September 5th

21 August 2023

ACTG Announces Publication of REPRIEVE Trial in New England Journal of Medicine and Presentation at IAS 2023

24 July 2023

Dr. Jane Simoni- New Role at the NIH

19 July 2023
Red Ribbon Registry

Red Ribbon Registry

The Red Ribbon Registry is a database of volunteers who are interested in participating in HIV/AIDS clinical trials.

Learn more here!

15 Trials Currently Enrolling

View Enrolling Trials